Latest News
From the Journals
Does Medicare Advantage Offer Higher-Value Chemotherapy?
Researchers conducted a cohort study to look at Medicare Advantage enrollment and treatment patterns for patients with cancer receiving...
Feature
AACR Cancer Progress Report: Big Strides and Big Gaps
The report focused on strides made in cancer care, prevention, and early detection and highlighted areas where more research and attention are...
Latest News
Screening Identifies Familial Risk for Hereditary Breast and Ovarian Cancer in Large Health System
The number needed to test to detect one BRCA1/2-positive patient decreased from 128 to 53 for women and from 119 to 42 for men when prescreening...
Feature
FDA’s Stricter Regulation of Lab-Developed Tests Faces Lawsuits and Lingering Concerns
Clinical laboratory lobbying groups are suing the FDA over its plans to more strictly regulate lab-developed tests. For now, physicians should see...
News from the FDA/CDC
FDA Expands Indication for Amivantamab in Lung Cancer
The second-line approval for amivantamab plus chemotherapy ‘may address the most common mechanisms of treatment resistance to third-generation...
From the Journals
Black Women Have a Higher Risk for Death in BC Subtypes
Researchers examined racial differences in BC survival by subtype through conducting a systematic review and meta-analysis of 18 US studies.
News from the FDA/CDC
FDA OKs Adjuvant Ribociclib in Earlier Stage Breast Cancer
The FDA also approved ribociclib and the aromatase inhibitor letrozole packaged together for the same indication.
News
Isatuximab Approved First-Line for Transplant-Ineligible MM
FDA greenlighted expansion of a biologic to treat patients newly diagnosed with myeloma for whom transplants are not an option.
Latest News
Is Intravenous Iron More Effective Than Oral Iron for Anemia During Pregnancy?
“Intravenous iron reduced the prevalence of iron deficiency to a greater extent than oral iron and was considered to be safe.”
Latest News
Melanoma: Neoadjuvant Immunotherapy Provides Optimal Survival Results
Those who received combination therapy achieved higher event- and recurrence-free survival than patients who received monotherapy.
Latest News
Identifying Drug-Induced Rashes in Skin of Color: Heightened Awareness Can Accelerate Diagnosis
In patients with DIHS and many of the even more serious types of rashes traced to drug exposures, the delay to appearance of the rash from the...